Pheniprazine, with the CAS number 55-52-7, is a chemical compound classified as a monoamine oxidase inhibitor (MAOI) and is primarily used in the treatment of depression. It belongs to the phenothiazine class of compounds and exhibits psychoactive properties. Pheniprazine functions by inhibiting the activity of monoamine oxidase enzymes, which are responsible for the breakdown of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. This inhibition leads to increased levels of these neurotransmitters, contributing to its antidepressant effects. The compound is typically administered in its hydrochloride salt form and is known for its potential side effects, including hypertensive crises when consumed with tyramine-rich foods. Additionally, it may cause sedation, dizziness, and other central nervous system effects. Due to safety concerns and the availability of newer antidepressants, the use of pheniprazine has declined in modern clinical practice. As with any medication, it is essential to use pheniprazine under medical supervision to monitor for adverse reactions and interactions with other drugs.

Pheniprazine

55-52-7: Pheniprazine, with the CAS number 55-52-7, is a chemical compound classified as a monoamine oxidase inhibitor (MAOI) and is primarily used in the treatment of depression. It belongs to the phenothiazine class of compounds and exhibits psychoactive properties. Pheniprazine functions by inhibiting the activity of monoamine oxidase enzymes, which are responsible for the breakdown of neurotransmitters such as serotonin, norepinephrine, and dopamine in the brain. This inhibition leads to increased levels of these neurotransmitters, contributing to its antidepressant effects. The compound is typically administered in its hydrochloride salt form and is known for its potential side effects, including hypertensive crises when consumed with tyramine-rich foods. Additionally, it may cause sedation, dizziness, and other central nervous system effects. Due to safety concerns and the availability of newer antidepressants, the use of pheniprazine has declined in modern clinical practice. As with any medication, it is essential to use pheniprazine under medical supervision to monitor for adverse reactions and interactions with other drugs.

Pheniprazine, a potent and long-acting monoamine oxidase inhibitor, shows promise for depression research.

CAS 55-52-7

Pheniprazine

Pheniprazine

Ref: TM-T69102